Job Watch

NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

Funding Opportunity RFA-RM-23-004 from the NIH Guide for Grants and Contracts. The NIH Directors Pioneer Award Program supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative research towards the ultimate goal of enhancing human health. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigators research program or elsewhere. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)

Funding Opportunity PAR-23-122 from the NIH Guide for Grants and Contracts. The NIH ?Research With Activities Related to Diversity (ReWARD) Program's overarching goal is to enhance the breadth and geographical location of research and research-related activities supported by NIH. The ReWARD program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding. The ReWARD program provides funding for both the scientific research and the DEIA activities of investigators. The grant will support scientific research in areas related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) and ongoing DEIA activities focused on enhancing diversity in the biomedical research enterprise within the United States and territories.

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-23-019 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to participate in the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network. The purpose of this FOA is to establish comprehensive, cooperative basic and translational research Centers to carry out in-depth research on prototype members of select virus families that have the potential to emerge as pandemic pathogens. The goal of these Centers will be to develop vaccine and monoclonal antibody strategies for prototype pathogen(s) that can be applied to closely related family members based on shared functional and structural properties. This FOA solicits for Centers proposing research on virus families from Flaviviridae and Togaviridae to be part of the ReVAMPP Network.

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-23-020 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to participate in the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network. The purpose of this FOA is to establish comprehensive, cooperative basic and translational research Centers to carry out in-depth research on prototype members of select virus families that have the potential to emerge as pandemic pathogens. The goal of these Centers will be to develop vaccine and monoclonal antibody strategies for prototype pathogen(s) that can be applied to closely related family members based on shared functional and structural properties. This FOA solicits for centers proposing research on virus families from Bunyavirales, Paramyxoviridae and Picornaviridae to be part of the ReVAMPP Network.

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-23-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to establish a Coordination and Data Sharing Center (CDSC) in support of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers. Together, the CDSC and ReVAMPP Centers will form the ReVAMPP Network. The purpose of the CDSC is to support, coordinate, and manage ongoing and planned activities within the ReVAMPP Network. The CDSC is expected to establish and maintain a collaborative ReVAMPP Network platform for data sharing as needed to harmonize reagents, assays, animal models and exchange knowledge on structure/function-based vaccine solutions and antigen/immunogen design as well as assess the utility of vaccine technology platforms for virus families studied under the ReVAMPP Centers. The CDSC is also expected to facilitate effective communications across the ReVAMPP Centers by scheduling, and managing all meetings, tracking overall network progress and outputs, developing opportunities for collaboration among the Centers such as establishing working groups, and under the direction of NIAID, collating information and facilitating exchange with other NIAID/NIH programs, U.S. Government (USG)partners, and other key stakeholders, including the World Health Organization (WHO), Bill and Melinda Gates Foundation (BMGF), and Coalition for Epidemic Preparedness Innovations (CEPI) among others as appropriate.

Principal Clinical Data Associate - Seagen - Bothell, WA

Indeed.com - Bioinformatics - Wed, 2023-03-15 20:11
Represent Data Management in governance bodies, product teams and cross-functional groups; lead internal working groups. BA/BS in relevant field. $119,000 - $154,000 a year
From Seagen - Thu, 16 Mar 2023 00:11:18 GMT - View all Bothell, WA jobs
Categories: Job Watch

Senior Clinical Data Associate - Seagen - Bothell, WA

Indeed.com - Bioinformatics - Wed, 2023-03-15 20:11
The Sr. CDA is responsible for leading Data Management aspects of a clinical study with minimal support and oversight and will ensure that study level… $102,000 - $132,000 a year
From Seagen - Thu, 16 Mar 2023 00:11:18 GMT - View all Bothell, WA jobs
Categories: Job Watch

Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed)

Funding Opportunity PAR-23-123 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a diverse workforce, which includes individuals from backgrounds that are not well represented in biomedical research (see NIH Interest in Diversity: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html), to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. The purpose of this PAR is twofold: 1) develop, implement, and evaluate modules of genomics-related curriculum for the diverse entry-level biomedical research workforce by supporting lead sites teamed with partner sites, such as community, technical, or tribal colleges; and 2) support and facilitate opportunities for the entry-level research workforce to enhance diversity in genomics. The training modules will be made freely available, at no cost to the broader community.

EMBL: Jobs at EMBL-EBIEnsembl Comparative Genomics Project Leader

New Scientist - Bioinformatics - Wed, 2023-03-15 13:20
Competitive Salary: EMBL: The Ensembl project seeks a talented and motivated Project Leader to manage its activities in the area of comparative genomics.  Ensemblis a world-le Hinxton, Cambridgeshire, England
Categories: Job Watch

EMBL: Jobs at EMBL-EBIPostdoctoral Fellow – Birney Research (IndiGene)

New Scientist - Bioinformatics - Wed, 2023-03-15 13:20
Competitive Salary: EMBL: We are looking for an experienced post-doctoral fellow with a strong background in Bioinformatics and a proven track record in genomic data analysis t Hinxton, Cambridgeshire, England
Categories: Job Watch

EMBL: Jobs at EMBL-EBIScientific Curator

New Scientist - Bioinformatics - Wed, 2023-03-15 13:18
Competitive Salary: EMBL: The Genome Interpretation team builds resources to enable the use of genomic data in clinical settings. We develop the Gene2Phenotype (G2P) system, wh Hinxton, Cambridgeshire, England
Categories: Job Watch

EMBL: Jobs at EMBL-EBISenior User Experience Designer

New Scientist - Bioinformatics - Wed, 2023-03-15 13:18
Competitive Salary: EMBL: We are looking for an experienced User Experience (UX) Designer to join the European Bioinformatics Institute (EMBL-EBI) in our mission to create scie Hinxton, Cambridgeshire, England
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch